title: Is radiotherapy still necessary for diffuse large B-cell lymphoma therapy?
authors.affiliation: Department of Human Pathology, University of Messina , Messina , Italy.
authors.forename: Patrizia
authors.initials: P
authors.lastname: Mondello
authors.forename: Salvatore
authors.initials: S
authors.lastname: Cuzzocrea
authors.forename: Vincenzo
authors.initials: V
authors.lastname: Pitini
authors.forename: Carmela
authors.initials: C
authors.lastname: Aloisi
authors.forename: Michael
authors.initials: M
authors.lastname: Mian
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy / Q000532:radiotherapy*; D049268:Positron-Emission Tomography; D011241:Prednisone / Q000627:therapeutic use; D000069283:Rituximab / Q000008:administration & dosage; D014750:Vincristine / Q000627:therapeutic use
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; C571759:R-CHOP protocol; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone